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Actinomycetes populate soils and aquatic sediments that impose biotic and abiotic 
challenges for their survival. As a result, actinomycetes metabolism and genomes have 
evolved to produce an overwhelming diversity of specialized molecules. Polyketides, 
non-ribosomal peptides, post-translationally modified peptides, lactams, and terpenes 
are well-known bioactive natural products with enormous industrial potential. Accessing 
such biological diversity has proven difficult due to the complex regulation of cellular 
metabolism in actinomycetes and to the sparse knowledge of their physiology. The past 
decade, however, has seen the development of omics technologies that have signifi-
cantly contributed to our better understanding of their biology. Key observations have 
contributed toward a shift in the exploitation of actinomycete’s biology, such as using 
their full genomic potential, activating entire pathways through key metabolic elicitors and 
pathway engineering to improve biosynthesis. Here, we review recent efforts devoted to 
achieving enhanced discovery, activation, and manipulation of natural product biosyn-
thetic pathways in model actinomycetes using genome-scale biological datasets.
Keywords: actinomycetes, genome mining, genomics, transcriptomics, proteomics, metabolomics, genome-
scale metabolic reconstructions
inTRODUCTiOn
Actinomycetes represent one of the largest bacterial phyla and are primary contributors to carbon 
cycling and a major source of bioactive natural products (BNP) including, most prominently, 
antibiotics. Despite their prime importance, our understanding of actinomycete’s biology remains 
elusive owing to a characteristically large, convoluted, high GC content genome (Demain, 2014). 
The complexity of actinomycetes genomes was only fully revealed in the last decade as part of the 
genomic revolution. Sequencing of the first actinomycetes genomes revealed a plethora of bioac-
tive secondary metabolites yet to be discovered in addition to the well-characterized biosynthetic 
gene clusters (BGC) (Doroghazi et al., 2014). According to NCBI database, to date around 1,000 
actinomycete genomes have been fully sequenced and annotated. Homology sequence-based 
bioinformatic tools have confirmed their great potential as BNP producers; for example, species 
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of Streptomyces, Salinispora, and Saccharopolyspora families 
contain an average of 30 secondary metabolite gene clusters 
(Nett et al., 2009).
The physiological changes leading to BNP biosynthesis in 
actinomycetes have been thoroughly studied over the past 
10 years. Considerable work has advanced our understanding 
of the transitional stage triggering BNP biosynthesis (also 
known as the “metabolic switch”; Alam et al., 2010) and with 
it, our understanding of the physiological changes leading to 
secondary pathways activation. However, a lack of full under-
standing of this physiological transition stage has prevented us 
from manipulating fully this cellular process using metabolic 
engineering. Here, we review landmark studies contributing 
to the discovery, activation, and manipulation of metabolic 
pathways for BNP through the development of genome-wide 
biological datasets and systems biology in actinomycetes 
(Figure 1).
PATHwAY DiSCOveRY: FROM iMPROveD 
GenOMe AnnOTATiOn TO THe 
DiSCOveRY OF new BnP BiOSYnTHeTiC 
PATHwAYS
Genome annotation is the basis for pathway discovery and 
manipulation. Pathway discovery typically follows a defined 
pipeline: genome sequencing, annotation, gene discovery, 
and pathway manipulation. The exponential increase in 
sequencing efficiency is yielding an ever-increasing num-
ber of sequenced genomes, causing a bottleneck due to an 
often limited understanding of genome sequences. In  silico 
approaches mainly rely on sequence homology scores to 
experimentally characterized sequences. Historically, how-
ever, functional microbiology has focused on a handful of 
microorganisms. Therefore, the genomic space for in  silico 
genome annotation pipelines is biased for certain G + C con-
tent sequences, gene length, and organization. For instance, 
approximately 60% of the bacterial genomic space is miss-
annotated in terms of gene boundaries (start/stop codons) 
caused by minimal cross-checks between computationally 
assigned open-reading frames (ORFs) and real genes (Nielsen 
and Krogh, 2005).
Bioinformatics-based pipelines failed to annotate accurately 
short-length proteins and high G + C content sequences in an 
annotation effort for 46 bacterial and archaea genomes (Venter 
et  al., 2011). By contrast, functional annotations supported 
by “omics technologies” dramatically improve gene function 
assignment, particularly in less characterized microorgan-
isms such as Geobacter sulfurreducens (Qiu et  al., 2010) or 
the erythromycin producer actinomycete Saccharopolyspora 
erythraea (Marcellin et  al., 2013a). Integration of proteomics 
and transcriptomics approaches has led to the re-annotation 
of these genomes, allowing for correction of hundreds of gene 
boundaries, the confirmation of hypothetical proteins and the 
discovery of dozens of new genes. A combination of proteomics 
and genomics, also known as proteogenomics, has also been 
used to deliver unbiased correlations between genome sequence 
and protein expression (Gupta et al., 2007; Gallien et al., 2009; 
Armengaud, 2010; Castellana and Bafna, 2010; Marcellin et al., 
2013a).
Genome Mining and Pathway Discovery
The first sequenced genomes of BNP producers were Streptomyces 
coelicolor (Bentley et al., 2002), Streptomyces avermitilis (Ikeda 
et  al., 2003), producer of the insecticide/anthelmintic aver-
mectin, S. erythraea (Oliynyk et al., 2007) and producer of the 
classic antibiotic streptomycin Streptomyces griseus (Ohnishi 
et al., 2008). Further sequence inspection of such genomes and 
other model actinomycetes have opened a plethora of BGCs, 
and revealed the great potential of actinomycetes genomes for 
the production of BNPs (Nett et  al., 2009; Aigle et  al., 2014; 
Doroghazi et  al., 2014; Ikeda et  al., 2014). However, exploit-
ing this rich source of BNP has proven challenging. Genomic 
analyses show an abundance of known BGCs (i.e., chemically 
and genetically known), hypothetical BCGs (i.e., chemically 
unknown – genetically known), and cryptic BCGs (i.e., chemi-
cally unknown  –  genetically unknown) (Zerikly and Challis, 
2009; Doroghazi and Metcalf, 2013).
Initial approaches to the discovery and identification of BNP 
were based on the search for cryptic BGC. The most common 
method involves gene mapping of enzymatic assembly complexes 
such as polyketide synthases (PKSs), non-ribosomal peptide 
synthases (NRPSs), and other enzymes typically related to BNPs 
(e.g., lanthipeptide synthases, terpene synthases, etc.). While 
simplistic, accumulation of structural, mechanistic, genetic, 
and chemical information on PKs and NRPs has allowed for 
the prediction of structures and chemical properties of dozens 
of BCGs from DNA sequences (Walsh et al., 2006; Hertweck, 
2009; Jenke-Kodama and Dittmann, 2009; Koglin and Walsh, 
2009; Walsh and Fischbach, 2010). Incorporating these mining 
strategies in specialized bioinformatic pipelines has revolu-
tionized the genome mining scene efficiency. Genome-scale 
prediction of putative BGCs is nowadays possible within a few 
of hours.
Continuous progress has enabled the emergence of bioin-
formatics platforms, such as CLUSEAN (Weber et  al., 2009), 
ClustScan (Starcevic et  al., 2008), np.searcher (Li et  al., 2009), 
SMURF (Khaldi et al., 2010), and antiSMASH (Medema et al., 
2011b; Blin et  al., 2013; Weber et  al., 2015). The latter is the 
most popular system for automated BNP genome mining since 
it analyzes BGC domains to propose loci, chemical scaffold, 
and putative chemical structures. However, one of the biggest 
disadvantages of the use of these genome mining approaches is 
their intrinsic limitations to BGCs from known chemical struc-
tures. Complementary approaches have emerged to enable the 
discovery of novel BCGs, such as ClusterFinder (Cimermancic 
et  al., 2014) or EvoMining (Medema and Fischbach, 2015). 
ClusterFinder uses hidden Markov model-based algorithms and 
Pfam as search database to annotate BCGs by clusters of protein 
domains with a biosynthetic logic. The use of ClusterFinder has 
allowed the detection of previously unknown classes of BCGs 
(Cimermancic et  al., 2014). On the other hand, EvoMining is 
FiGURe 1 | Sequencing actinomycete genomes has revealed an unexpected complexity. Systems Biology has opened access to the untapped chemical 
diversity encoded within the global microbial genome, including the vast majority (>99%) of taxa that are currently deemed unculturable, and a wealth of  
bioactive genes that are currently silent (untranslated) under standard cultivation condition.
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a functional phylogenomic pipeline that identifies expanded, 
repurposed enzyme families, with the potential to catalyze new 
conversions within BGC (Medema and Fischbach, 2015). This 
innovative method embraces the predictive power of evolu-
tionary theory leading to model-independent predictions that 
include gene clusters that do not follow traditional biosynthetic 
rules. The method has been used for the discovery of the genes 
directing synthesis of small peptide aldehydes and the first bio-
synthetic system for arseno-organic metabolites.
Overall, genomic approaches have significantly improved 
the prediction of BNP from unannotated sequences and pro-
vided deep insights into the identification of novel chemical 
species. The genomic approach is limited to the known rep-
ertoire of BCGs, ignoring regulatory information for pathway 
activation.
PATHwAY ACTivATiOn: SYSTeMS 
BiOLOGY AnALYSiS OF ACTinOMYCeTe 
PHYSiOLOGY AnD DeveLOPMenT
Systems biology protocols have been successfully used to describe 
germination (Piette et al., 2005; Yagüe et al., 2013a; Bobek et al., 
2014), programed cell death (Manteca et al., 2005), diauxic lag 
phase (Novotna et al., 2003), mutant analyses (bald A mutant) 
(Kim et  al., 2005; Hesketh et  al., 2007), and phosphate limita-
tion (Rodríguez-García et al., 2007). Given that biosynthesis of 
natural products in actinomycetes is conceived as a physiological 
response to environmental changes (e.g., change of temperature, 
nutritional conditions, etc.), it is assumed that understanding 
their physiological behavior would provide the lead for natural 
product pathway activation and manipulation. Here, we focus on 
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reviewing efforts devoted to understand the physiological transi-
tions prior the activation of known natural product biosynthesis 
and the approaches used for the activation of unknown natural 
products biosynthetic pathways in model actinomycetes.
Physiological Transitions and 
Development
Actinomycetes undergo drastic physiological changes dur-
ing their developmental cycle (i.e., programed cell death and 
sporulation). In contrast to previous assumptions that sporula-
tion events exclusively occurred in solid cultures (Flardh and 
Buttner, 2009), differentiation during pre-sporulation stages have 
been described in both solid and liquid Streptomyces cultures 
(Manteca et al., 2010). The existence of two different mycelia (MI 
and MII) across the developmental cycle has been characterized 
using iTRAQ LC-MS/MS proteomics, phosphoproteomics, and 
microarray-based transcriptomics (Manteca et  al., 2010, 2011; 
Yagüe et al., 2013b). Specifically, proteins involved in antibiotic 
biosynthesis were upregulated in MII, and primary metabolism 
proteins from glycolysis, protein biosynthesis, and tricarboxylic 
acid cycle were upregulated in the MI. The second multinucleated 
mycelium with (aerial) and without (substrate) hydrophobic cov-
ers constituted a unique reproductive structure (Manteca et al., 
2010). The most remarkable differences between MII from solid 
and liquid cultures involved proteins regulating the final stages 
of hyphae compartmentalization and spore formation (Manteca 
et al., 2010).
Similarly, characterization of the S. erythraea developmental 
cycle in bioreactors has been explored at base resolution tran-
scription (RNA-seq), proteome (iTRAQ) and phosphoproteome 
(sMRM) (Marcellin et al., 2013a,b; Licona-Cassani et al., 2014) 
(Figure  2). The studies focused on the metabolic switch, a 
distinct transformational event that bisects two growth phases 
in actinomycetes and is characterized by rapid molecular and 
morphological changes. Authors found that the S. erythraea 
transcriptome undergoes extensive events of targeted mRNA 
degradation and transcription of mRNAs for adaptive metabolic 
functions, thereby resetting cells for the induction of a replace-
ment transcriptional program. A suite of RNase and proteases 
mediate a targeted destruction of the transcriptome and pro-
teome (suicidal patterns) in concert with the shifting of broad 
transcription macro-domains, delineated by core/non-core 
genomic regions. In addition, the temporal-dynamic, semi-
quantitative phosphoproteomic study revealed that proteins from 
central metabolism (putative acetyl-CoA carboxylase, isocitrate 
lyase, and 2-oxoglutarate dehydrogenase) and key developmental 
pathways (trypsin-like serine protease, ribonuclease Rne/Rng, 
and ribosomal proteins) in S. erythraea change dramatically the 
degree of phosphorylation across the developmental cycle in 
liquid cultures (Figure 2) (Licona-Cassani et al., 2014).
One of the most significant observations linking actinomycete 
physiological behavior and pathway activation was made by Nieselt 
and collaborators (Nieselt et al., 2010). Using a temporal-dynamic 
transcriptomic analysis, Nieselt and collaborators identified the 
existence of several transitional stages along the fermentation that 
coincide with activation of natural product metabolic pathways 
in S. coelicolor (Nieselt et al., 2010). Under their bioreactor set-
tings, early coordinated gene expression changes of genes related 
to nitrogen metabolism, including glutamine synthases I and II 
and the signaling protein GlnK is observed under similar tempo-
ral space as genes from the CPK antibiotic biosynthetic pathway. 
Interestingly, such transcriptional changes were observed under 
nitrogen sufficiency conditions. In addition, an unexpected 
transcriptional switch for developmental genes, such as chap-
lins, bldN, and whiH was registered showing for the first time 
that developmental genes are transcribed in S. coelicolor liquid 
cultures. Finally, the traditional metabolic switch was observed 
by a strong upregulation of the pho regulon together with the 
upregulation of the pigmented antibiotic undecylprodigiosin and 
actinorhodin (Nieselt et al., 2010).
While we are still far from overcoming the physiological 
barrier of achieving pathway activation and exploiting the full 
genomic potential of actinomycetes, systems biology approaches 
have significantly contributed to shifting key paradigms. First, we 
know that pathway activation does not follow the same regulatory 
rules to model actinomycetes (e.g., S. coelicolor or Mycobacterium 
tuberculosis); in fact, it is now possible to understand such differ-
ences in a single experiment. More importantly, systems biology 
has exposed a subset of strain-metabolite-specific regulatory 
mechanisms such as non-coding RNAs (Marcellin et al., 2013b), 
dynamic phosphorylation of ribosomal proteins (Licona-Cassani 
et  al., 2014), acetylation of RNA degradation-related proteins 
(Huang et  al., 2015), among others. The last part of this mini, 
review focuses on the efforts to manipulate metabolic pathways 
in actinomycetes using genome-scale metabolic reconstructions 
and metabolic engineering strategies.
PATHwAY MAniPULATiOn: FROM 
RATiOnAL DeSiGn TO GenOMe-SCALe 
MODeL – GUiDeD MeTABOLiC 
enGineeRinG STRATeGieS in 
ACTinOMYCeTeS
Production processes with sub-hundreds of mg/L product titers 
are considered unsustainable for industrial scale production. 
Actinomycetes cultures are also slow growing and unpredictable 
even under controlled conditions (i.e., bioreactor fermentations), 
and as such are difficult to ferment. For over 50  years, entire 
teams of metabolic and bioprocess engineers have used classical 
approaches such as random mutagenesis rounds (Tanaka et al., 
2009; Jung et al., 2011), media design, and process optimization 
(Hamedi et al., 2004; El-Enshasy et al., 2008; Zou et al., 2009), 
and rationally designed metabolic engineering strategies (Reeves 
et al., 2006, 2007; Olano et al., 2008) to engineer actinomycetes 
bioprocesses and strains to achieve acceptable titers. Modern 
strain engineering uses genome-scale models (GEMs) in com-
bination with omics data for the integration of genome-scale 
biological datasets toward the manipulation of metabolism.
Since the first GEM release, more than a decade ago (Edwards 
and Palsson, 1999), applications have expanded from in  silico 
metabolic predictions (Edwards and Palsson, 2000; Schilling 
et al., 2002; Park et al., 2007) to the discovery of antibacterial 
FiGURe 2 | Systems biology aims at understanding the larger picture of actinomycete’s biology – at the level of the organism – by putting its pieces 
together rather than apart. It is in stark contrast to decades of reductionist biology in the area of actinomycete’s biology. For example, this figure illustrates the 
comprehensive multi-omics characterization of the S. erythraea metabolism across a fermentation time-course. As in most actinomycetes, at the 50th hour, there is 
a characteristic metabolic transition, which dictates the production of erythromycin. This figure illustrates how this transition is characterized by a massive loss of 
proteins and ribosomal RNA before a new expression pattern emerges. Around 30% of all transcripts arose from previously unannotated DNA and detailed analysis 
revealed approximately 350 new coding genes and 300 non-coding genes. Systems biology can unravel the complex nature of actinomycete’s biology at the 
transcriptomics, metabolomics, and proteomics level revealing various novel non-coding RNAs and uncharacterized phosphorylation patterns.
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targets (Oberhardt et al., 2009; Kim et al., 2010), integration of 
biological datasets (Lerman et al., 2012; Imam et al., 2015), phe-
notype prediction (O’Brien et al., 2013), estimation of metabolic 
capabilities (O’Brien et al., 2015), and the study of evolutionary 
relationships of metabolic and regulatory networks (Oberhardt 
et al., 2009; Kim et al., 2010; Barona-Gomez et al., 2012).
While draft GEM are now routinely generated using high-
throughput automated pipelines (Aziz et al., 2008; Henry et al., 
2010), successful applications of GEMs to microbial metabolism 
only have occurred on exhaustively (manually) curated/experi-
mentally validated metabolic reconstructions. In this regard, 
despite being our primary microbial source for antibiotics, only 
a handful of manually curated GEM for actinomycetes have been 
reported (Borodina et al., 2005a; Beste et al., 2007; Jamshidi and 
Palsson, 2007; Alam et  al., 2010; Medema et  al., 2010, 2011a; 
Chindelevitch et al., 2012; Licona-Cassani et al., 2012). Even more 
surprising is the fact that pathway optimization of actinomycete 
metabolism has only been achieved at the level of precursor sup-
ply (Borodina et  al., 2005b, 2008; Licona-Cassani et  al., 2012). 
In such approaches, optimal solutions are found because there is 
congruence between cellular (maximize growth rate) and engi-
neering objectives (maximize productivity). In order to properly 
optimize production of non-growth-associated metabolites (i.e., 
BNP) novel algorithms and new objective functions are to be 
incorporated to current protocols.
The last few years have seen the emergence of network recon-
struction beyond metabolism. These next-generation network 
reconstructions account for expression coupled to metabolism 
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and even transcriptional regulation. The first such model, 
known as ME-model, was developed for Thermotoga maritima 
(Zhang et al., 2009; Lerman et al., 2012) rapidly followed by the 
Escherichia coli ME-model (O’Brien et al., 2013). Incorporation 
of gene expression in the mathematical framework allows these 
models to expand their predictive capabilities, which may be 
what is needed to model non-growth-associated metabolites 
such as BNPs. It is expected that as ME-models for actinomycetes 
become available, just like GEMs became available 10 years ago, 
multi-omics integration may be possible, and with it, models 
become more predictive.
FUTURe DiReCTiOnS
Like in model organisms, such as yeast and E. coli, systems biology 
in actinomycetes has immensely advanced our understanding of 
this complex and fascinating bacterial family, offering insightful 
information regarding gene discovery, gene regulation, and pathway 
manipulation. The tools are highly developed and readily available 
yet integration and data analysis remain our main challenge. Just like 
finding a needle in a haystack, finding a key gene in a sea of data is 
extremely challenging; the main challenge remains the lack of tools 
for integration and visualization of large datasets. As such, systems 
biology in actinomycetes has yet to deliver real advances for the 
production of BNPs and discovery of novel bioactive compounds.
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